Dana‑Farber Cuts Brigham Tie, Staff Feel ‘Divorce’
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Dana-Farber Cancer Institute announced in September 2023 that it would end its decades‑long partnership with Brigham and Women’s Hospital.
- Brigham and Women’s Hospital and Dana-Farber will unwind the partnership incrementally, with the contract slated to terminate in 2028.
- Dana-Farber will partner with Beth Israel Deaconess Medical Center to develop a new cancer hospital, projected to open in 2031.
- Dana-Farber staff describe a growing sense of awkwardness, likening the split to a divorce within a household.
- Boston’s medical community initially found the announcement shocking, but the breakup has become increasingly messy as staff adjust to the new arrangement.
Why it matters: The split strips Dana‑Farber staff of the collaborative environment they had with Brigham, while Beth Israel Deaconess gains a high‑profile partner. The delayed 2031 opening postpones patient access and research opportunities, and the 2028 contract end reshapes financial and operational duties for both hospitals.
Ask SkimNews
